ID   SPRE_HUMAN              Reviewed;         261 AA.
AC   P35270; A8K741; D6W5H2; Q53GI9; Q9UBB1;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=Sepiapterin reductase;
DE            Short=SPR;
DE            EC=1.1.1.153;
GN   Name=SPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1883349; DOI=10.1016/0006-291X(91)91352-D;
RA   Ichinose H., Katoh S., Sueoka T., Titani K., Fujita K., Nagatsu T.;
RT   "Cloning and sequencing of cDNA encoding human sepiapterin reductase
RT   -- an enzyme involved in tetrahydrobiopterin biosynthesis.";
RL   Biochem. Biophys. Res. Commun. 179:183-189(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8440319; DOI=10.1006/excr.1993.1027;
RA   Maier J., Schott K., Werner T., Bacher A., Ziegler I.;
RT   "Detection of a novel sepiapterin reductase mRNA: assay of mRNA in
RT   various cells and tissues of various species.";
RL   Exp. Cell Res. 204:217-222(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Salivary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9792819; DOI=10.1006/bbrc.1998.9503;
RA   Ohye T., Hori T.A., Katoh S., Nagatsu T., Ichinose H.;
RT   "Genomic organization and chromosomal localization of the human
RT   sepiapterin reductase gene.";
RL   Biochem. Biophys. Res. Commun. 251:597-602(1998).
RN   [9]
RP   KINETIC PARAMETERS, PHOSPHORYLATION AT SER-213, AND MUTAGENESIS OF
RP   SER-213.
RX   PubMed=11825621; DOI=10.1016/S0167-4838(01)00300-4;
RA   Fujimoto K., Takahashi S.Y., Katoh S.;
RT   "Mutational analysis of sites in sepiapterin reductase phosphorylated
RT   by Ca2+/calmodulin-dependent protein kinase II.";
RL   Biochim. Biophys. Acta 1594:191-198(2002).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 5-261 IN COMPLEX WITH NADP.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human sepiapterin reductase.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [14]
RP   VARIANT DRDSPRD GLY-150.
RX   PubMed=11443547; DOI=10.1086/321970;
RA   Bonafe L., Thony B., Penzien J.M., Czarnecki B., Blau N.;
RT   "Mutations in the sepiapterin reductase gene cause a novel
RT   tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency
RT   without hyperphenylalaninemia.";
RL   Am. J. Hum. Genet. 69:269-277(2001).
RN   [15]
RP   VARIANT DRDSPRD LEU-163.
RX   PubMed=16650784; DOI=10.1016/j.ymgme.2006.03.010;
RA   Abeling N.G.G.M., Duran M., Bakker H.D., Stroomer L., Thoeny B.,
RA   Blau N., Booij J., Poll-The B.T.;
RT   "Sepiapterin reductase deficiency an autosomal recessive DOPA-
RT   responsive dystonia.";
RL   Mol. Genet. Metab. 89:116-120(2006).
RN   [16]
RP   VARIANT DRDSPRD GLY-150.
RX   PubMed=17159114; DOI=10.1212/01.wnl.0000247274.21261.b4;
RA   Friedman J., Hyland K., Blau N., MacCollin M.;
RT   "Dopa-responsive hypersomnia and mixed movement disorder due to
RT   sepiapterin reductase deficiency.";
RL   Neurology 67:2032-2035(2006).
CC   -!- FUNCTION: Catalyzes the final one or two reductions in tetra-
CC       hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin.
CC   -!- CATALYTIC ACTIVITY: L-erythro-7,8-dihydrobiopterin + NADP(+) =
CC       sepiapterin + NADPH.
CC   -!- CATALYTIC ACTIVITY: L-erythro-tetrahydrobiopterin + 2 NADP(+) = 6-
CC       pyruvoyl-5,6,7,8-tetrahydropterin + 2 NADPH.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=14.3 uM for sepiapterin {ECO:0000269|PubMed:11825621};
CC         KM=10 uM for NADPH {ECO:0000269|PubMed:11825621};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|Ref.13}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- PTM: In vitro phosphorylation of Ser-213 by CaMK2 does not change
CC       kinetic parameters. {ECO:0000269|PubMed:11825621}.
CC   -!- DISEASE: Dystonia, DOPA-responsive, due to sepiapterin reductase
CC       deficiency (DRDSPRD) [MIM:612716]: A form of DOPA-responsive
CC       dystonia. In the majority of cases, patients manifest progressive
CC       psychomotor retardation, dystonia and spasticity. Cognitive
CC       anomalies are also often present. The disease is due to severe
CC       dopamine and serotonin deficiencies in the central nervous system
CC       caused by a defect in BH4 synthesis. Dystonia is defined by the
CC       presence of sustained involuntary muscle contractions, often
CC       leading to abnormal postures. {ECO:0000269|PubMed:11443547,
CC       ECO:0000269|PubMed:16650784, ECO:0000269|PubMed:17159114}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the sepiapterin reductase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M76231; AAA60314.1; -; mRNA.
DR   EMBL; AK291856; BAF84545.1; -; mRNA.
DR   EMBL; AK222942; BAD96662.1; -; mRNA.
DR   EMBL; AC092630; AAY15035.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99757.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99758.1; -; Genomic_DNA.
DR   EMBL; BC017310; AAH17310.1; -; mRNA.
DR   EMBL; AB017547; BAA34534.1; -; Genomic_DNA.
DR   CCDS; CCDS1920.1; -.
DR   PIR; JQ1176; JQ1176.
DR   RefSeq; NP_003115.1; NM_003124.4.
DR   UniGene; Hs.301540; -.
DR   PDB; 1Z6Z; X-ray; 2.50 A; A/B/C/D/E/F=5-261.
DR   PDB; 4HWK; X-ray; 2.40 A; A/B/C/D=1-261.
DR   PDB; 4J7U; X-ray; 2.44 A; A/B/C/D=1-261.
DR   PDB; 4J7X; X-ray; 2.60 A; A/B/F/J=1-261.
DR   PDB; 4XWY; X-ray; 2.35 A; A/B/C/D=1-261.
DR   PDB; 4Z3K; X-ray; 2.35 A; A/B/C/D=1-261.
DR   PDBsum; 1Z6Z; -.
DR   PDBsum; 4HWK; -.
DR   PDBsum; 4J7U; -.
DR   PDBsum; 4J7X; -.
DR   PDBsum; 4XWY; -.
DR   PDBsum; 4Z3K; -.
DR   ProteinModelPortal; P35270; -.
DR   SMR; P35270; -.
DR   BioGrid; 112575; 48.
DR   IntAct; P35270; 1.
DR   MINT; MINT-3304575; -.
DR   STRING; 9606.ENSP00000234454; -.
DR   BindingDB; P35270; -.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   DrugBank; DB03886; Biopterin.
DR   DrugBank; DB04275; N-Acetyl Serotonin.
DR   DrugBank; DB02637; Oxaloacetate Ion.
DR   iPTMnet; P35270; -.
DR   PhosphoSitePlus; P35270; -.
DR   BioMuta; SPR; -.
DR   DMDM; 464801; -.
DR   EPD; P35270; -.
DR   MaxQB; P35270; -.
DR   PaxDb; P35270; -.
DR   PeptideAtlas; P35270; -.
DR   PRIDE; P35270; -.
DR   DNASU; 6697; -.
DR   Ensembl; ENST00000234454; ENSP00000234454; ENSG00000116096.
DR   GeneID; 6697; -.
DR   KEGG; hsa:6697; -.
DR   UCSC; uc002sik.3; human.
DR   CTD; 6697; -.
DR   DisGeNET; 6697; -.
DR   GeneCards; SPR; -.
DR   HGNC; HGNC:11257; SPR.
DR   HPA; HPA039505; -.
DR   MalaCards; SPR; -.
DR   MIM; 182125; gene.
DR   MIM; 612716; phenotype.
DR   neXtProt; NX_P35270; -.
DR   OpenTargets; ENSG00000116096; -.
DR   Orphanet; 70594; Dopa-responsive dystonia due to sepiapterin reductase deficiency.
DR   PharmGKB; PA36087; -.
DR   eggNOG; KOG1204; Eukaryota.
DR   eggNOG; ENOG4111PZG; LUCA.
DR   GeneTree; ENSGT00440000033609; -.
DR   HOVERGEN; HBG006973; -.
DR   InParanoid; P35270; -.
DR   KO; K00072; -.
DR   OMA; VDCKVSA; -.
DR   OrthoDB; EOG091G0N30; -.
DR   PhylomeDB; P35270; -.
DR   TreeFam; TF326358; -.
DR   BioCyc; MetaCyc:HS03979-MONOMER; -.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   SIGNOR; P35270; -.
DR   ChiTaRS; SPR; human.
DR   EvolutionaryTrace; P35270; -.
DR   GeneWiki; Sepiapterin_reductase; -.
DR   GenomeRNAi; 6697; -.
DR   PRO; PR:P35270; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000116096; -.
DR   CleanEx; HS_SPR; -.
DR   Genevisible; P35270; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:UniProtKB.
DR   GO; GO:0050661; F:NADP binding; TAS:UniProtKB.
DR   GO; GO:0004757; F:sepiapterin reductase activity; ISS:UniProtKB.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; TAS:UniProtKB.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome.
DR   GO; GO:0006729; P:tetrahydrobiopterin biosynthetic process; TAS:UniProtKB.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR002347; SDR_fam.
DR   InterPro; IPR006393; Sepiapterin_red.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR01500; sepiapter_red; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Disease mutation; Dystonia; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    261       Sepiapterin reductase.
FT                                /FTId=PRO_0000072149.
FT   NP_BIND      14     20       NADP. {ECO:0000269|Ref.13}.
FT   NP_BIND      42     43       NADP. {ECO:0000269|Ref.13}.
FT   NP_BIND      69     70       NADP. {ECO:0000269|Ref.13}.
FT   NP_BIND     201    206       NADP. {ECO:0000269|Ref.13}.
FT   REGION      157    158       Substrate binding. {ECO:0000250}.
FT   BINDING     170    170       Substrate. {ECO:0000250}.
FT   BINDING     174    174       NADP. {ECO:0000250}.
FT   BINDING     199    199       Substrate; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     257    257       Substrate. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:P18297}.
FT   MOD_RES      32     32       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18297}.
FT   MOD_RES     103    103       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     213    213       Phosphoserine; by CaMK2; in vitro.
FT                                {ECO:0000269|PubMed:11825621}.
FT   VARIANT     150    150       R -> G (in DRDSPRD; dbSNP:rs104893665).
FT                                {ECO:0000269|PubMed:11443547,
FT                                ECO:0000269|PubMed:17159114}.
FT                                /FTId=VAR_058007.
FT   VARIANT     163    163       P -> L (in DRDSPRD; dbSNP:rs104893666).
FT                                {ECO:0000269|PubMed:16650784}.
FT                                /FTId=VAR_058008.
FT   MUTAGEN     213    213       S->A: Abolishes phosphorylation by CaMK2.
FT                                No effect on kinetic parameters.
FT                                {ECO:0000269|PubMed:11825621}.
FT   CONFLICT     10     10       C -> R (in Ref. 4; BAD96662).
FT                                {ECO:0000305}.
FT   STRAND        6     14       {ECO:0000244|PDB:4XWY}.
FT   HELIX        18     28       {ECO:0000244|PDB:4XWY}.
FT   STRAND       36     42       {ECO:0000244|PDB:4XWY}.
FT   HELIX        44     54       {ECO:0000244|PDB:4XWY}.
FT   HELIX        56     59       {ECO:0000244|PDB:4XWY}.
FT   STRAND       62     67       {ECO:0000244|PDB:4XWY}.
FT   HELIX        73     85       {ECO:0000244|PDB:4XWY}.
FT   STRAND       94     99       {ECO:0000244|PDB:4XWY}.
FT   HELIX       111    113       {ECO:0000244|PDB:4XWY}.
FT   HELIX       117    127       {ECO:0000244|PDB:4XWY}.
FT   HELIX       129    141       {ECO:0000244|PDB:4XWY}.
FT   STRAND      149    155       {ECO:0000244|PDB:4XWY}.
FT   HELIX       158    160       {ECO:0000244|PDB:4XWY}.
FT   HELIX       168    187       {ECO:0000244|PDB:4XWY}.
FT   STRAND      191    197       {ECO:0000244|PDB:4XWY}.
FT   STRAND      200    203       {ECO:0000244|PDB:4Z3K}.
FT   HELIX       204    212       {ECO:0000244|PDB:4XWY}.
FT   HELIX       216    227       {ECO:0000244|PDB:4XWY}.
FT   HELIX       234    247       {ECO:0000244|PDB:4XWY}.
FT   STRAND      254    257       {ECO:0000244|PDB:4XWY}.
SQ   SEQUENCE   261 AA;  28048 MW;  9C9BF76212826F47 CRC64;
     MEGGLGRAVC LLTGASRGFG RTLAPLLASL LSPGSVLVLS ARNDEALRQL EAELGAERSG
     LRVVRVPADL GAEAGLQQLL GALRELPRPK GLQRLLLINN AGSLGDVSKG FVDLSDSTQV
     NNYWALNLTS MLCLTSSVLK AFPDSPGLNR TVVNISSLCA LQPFKGWALY CAGKAARDML
     FQVLALEEPN VRVLNYAPGP LDTDMQQLAR ETSVDPDMRK GLQELKAKGK LVDCKVSAQK
     LLSLLEKDEF KSGAHVDFYD K
//
